Microsomal cytochrome P450 levels and activities of isolated rat livers perfused with albumin

Pharmaceutical Research

Volumn 20, Issue 1, 2003, Pages 81-88

  Vuppugalla, Ragini ^a   Shah, Rakhi B ^a   Chimalakonda, Anjaneya P ^a   Fisher, Charles W ^a,b   Mehvar, Reza ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Cedra   (United States)

Author keywords

Bovine serum albumin; Cytochrome P450; Drug metabolism; Lipopolysaccharide; Liver perfusion

Indexed keywords

BOVINE SERUM ALBUMIN; BUFFER; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; CYTOCHROME P450 2C11; CYTOCHROME P450 2D1; CYTOCHROME P450 2E1; CYTOCHROME P450 3A2; CYTOKINE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; LIVER MICROSOME; LIVER PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILE; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; ISOENZYMES; LIVER; MALE; MICROSOMES, LIVER; NADH DEHYDROGENASE; NITRATES; NITRITES; ORGAN SIZE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN, BOVINE;

EID: 0037261232     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022202926073     Document Type: Article

References (30)

1. E. T. Morgan. Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis. Biochem. Pharmacol. 45: 415-419 (1993).
2. P. Ghezzi, B. Saccardo, P. Villa, V. Rossi, M. Bianchi, and C. A. Dinarello. Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infect. Immun. 54:837-840 (1986).
3. M. Monshouwer, R. A. McLellan, E. Delaporte, R. F. Witkamp, A. S. van Miert, and K. W. Renton. Differential effect of pentoxifylline on lipopolysaccharide-induced downregulation of cytochrome P450. Biochem. Pharmacol. 52:1195-1200 (1996).
4. M. B. Sewer and E. T. Morgan. Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes. Biochem. Pharmacol. 54:729-737 (1997).
5. E. T. Morgan. Regulation of cytochromes P450 during inflammation and infection. Drug Metab. Rev. 29:1129-1188 (1997).
6. K. S. Pang. Liver perfusion studies in drug metabolism and drug toxicity. In J. R. Mitchell and M. G. Homing (eds.), Drug Metabolism and Drug Toxicity. Raven Press, New York, 1984, pp. 331-352.
7. A. M. Evans, Z. Hussein, and M. Rowland. Influence of albumin on the distribution and elimination kinetics of diclofenac in the isolated perfused rat liver: analysis by the impulse-response technique and dispersion model. J. Pharm. Sci. 82:421-428 (1993).
8. R. Mehvar. and J. Reynolds. Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers - role of protein binding. Drug Metab. Dispos. 24:1088-1094 (1996).
9. R. Mehvar and X. P. Zhang. Development and application of an isolated perfused rat liver model to study the stimulation and inhibition of tumor necrosis factor-α production ex vivo. Pharm. Res. 19:47-53 (2002).
10. B. G. Lake. Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism. In K. Snell and B. Mullock (eds.), Biochemical Toxicology, a Practical Approach. IRL Press, Oxford, United Kingdom, 1987, pp. 183-215.
11. M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
12. T. Omura and R. Sato. The carbon monoxide-binding pigment of the liver microsomes. Evidence for its hemoprotein nature. J. Biol. Chem. 239:2370-2378 (1964).
13. A. H. Phillips and R. G. Langdon. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterisation, and kinetic studies. J. Biol. Chem. 237:2652-2660 (1962).
14. M. P. Purdon and L. D. Lehman-McKeeman. Improved high-performance liquid chromatographic procedure for the separation and quantification of hydroxytestosterone metabolites. J. Pharmacol. Toxicol. Methods 37:67-73 (1997).
15. D. R. Koop. Hydroxylation of p-nitrophenol by rabbit ethanolinducible cytochrome P-450 isozyme 3A. Mol. Pharmacol. 29: 399-404 (1986).
16. 14C] Dextromethorphan as substrate. In E. F. Johnson and M. R. Waterman (eds.), Methods in Enzymology, Academic Press, San Diego, California, 1996, pp. 186-195.
17. M. D. Burke, S. Thompson, C. R. Elcombe, J. Halpert, T. Haaparanta, and R. T. Mayer. Ethoxy-, pentoxy- and benzyloxy-phenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34:3337-3345 (1985).
18. J. E. Snawder and J. C. Lipscomb. Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment. Regul. Toxicol. Pharmacol. 32:200-209 (2000).
19. K. Pang and M. Rowland. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J. Pharmacokinet. Biopharm. 5:625-653 (1977).
20. T.-A. Tran-Thi, L. Weinhold, C. Weinstock, R. Hoffmann, A. Schulze-Specking, H. Northoff, and K. Decker. Production of tumor necrosis factor-α, interleukin-1 and interleukin-6 in the perfused rat liver. Eur. Cytokine Netw. 4:363-370 (1993).
21. G. W. Warren, S. M. Poloyac, D. S. Gary, M. P. Mattson, and R. A. Blouin. Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration. J. Pharmacol. Exp. Ther. 288:945-950 (1999).
22. J. Liu, L. E. Sendelbach, A. Parkinson, and C. D. Klaassen. Endotoxin pretreatment protects against the hepatotoxicity of acetaminophen and carbon tetrachloride: role of cytochrome P450 suppression. Toxicology 147:167-176 (2000).
23. A. L. Roe, S. M. Poloyac, G. Howard, S. I. Shedlofsky, and R. A. Blouin. The effect of endotoxin on hepatocyte nuclear factor 1 nuclear protein binding: potential implications on CYP2E1 expression in the rat. J. Pharm. Pharmacol. 53:1365-1371 (2001).
24. M. B. Sewer and E. T. Morgan. Down-regulation of the expression of three major rat liver cytochrome P450s by endotoxin in vivo occurs independently of nitric oxide production. J. Pharmacol. Exp. Ther. 287:352-358 (1998).
25. S. Takemura, Y. Minamiyama, S. Imaoka, Y. Funae, K. Hirohashi, M. Inoue, and H. Kinoshita. Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia. J. Hepatol. 30:1035-1044 (1999).
26. L. Nadin, A. M. Butler, G. C. Farrell, and M. Murray. Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha. Gastroenterology 109:198-205 (1995).
27. T. J. Carlson and R. E. Billings. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Mol. Pharmacol. 49:796-801 (1996).
28. E. T. Morgan, K. B. Thomas, R. Swanson, T. Vales, J. Hwang, and K. Wright. Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochim. Biophys. Acta 1219:475-483 (1994).
29. R. Aldini, A. Roda, A. M. Morselli-Labate, P. Simoni, E. Roda, and L. Barbara. Effect of albumin on taurocholate uptake kinetics in rat liver. Clin. Sci. (Lon.) 72:11-17 (1987).
30. R. H. Moseley, W. Wang, H. Takeda, K. Lown, L. Shick, M. Ananthanarayanan, and F. J. Suchy. Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. Am. J. Physiol. 271:G137-G146 (1996).